Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALISA: Second-line Antiretroviral Strategies in African Adults
NCT01255371Phase 3Withdrawn
- Sponsor
- ANRS
- Start
- Mar 2012
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of atazanavir in human immunodeficiency virus type 1 infection (HIV-1), sponsored by ANRS. Planned start Mar 2012; status: withdrawn.
02
Drugs
atazanavir
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01255371.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01255371.